Fabio Martinelli
drfmartinelli.bsky.social
Fabio Martinelli
@drfmartinelli.bsky.social
Assistant Professor at Humanitas University and Director of the Gynecologic Oncology Surgical Division at Humanitas PioX – Milan Italy. All posts are my own.
Pinned
December 15, 2024 at 9:33 PM
Reposted by Fabio Martinelli
📌 Association Between Risk-Reducing Surgeries and Survival in Young BRCA Carriers with Breast Cancer: Results from an International Cohort Study presented by prof Matteo Lambertini 👏🏻
#SABCS24 #GeneralSession1 #day2 @oncoalert.bsky.social #OncoAlertAF
December 11, 2024 at 5:22 PM
Reposted by Fabio Martinelli
📌 Educational Session 1: Mind the Gap - Breast Cancer in the Young
“Ovarian Suppression: Who, When, Why, and for How Long” great presentation by Prudence Francis 👏🏻
#SABCS24 #day1 @oncoalert.bsky.social #OncoAlertAF
December 10, 2024 at 11:16 PM
Reposted by Fabio Martinelli
Managing Germline Mutations in #BreastCancer Risk: Results from inherited mutations are primarily in #BRCA genes. Additional genes like #TP53, #PTEN, #PALB2, #CHEK2, & #ATM also contribute to #hereditarycancer risk @AJMC_Journal

#genetics #bcsm #hereditarycancer

www.ajmc.com/view/managin...
Managing Germline Mutations in Hereditary Breast Cancer Risk
Hereditary breast cancers are caused by germline mutations, which are genetic mutations inherited at conception and so called because they originate in germ cells, those that develop into reproductive...
www.ajmc.com
November 23, 2024 at 4:10 PM
Vaginal Estrogen Use in #breastcancer Survivors: A Systematic Review and Meta-Analysis of Recurrence and Mortality Risks @AJOG_thegray ajog.org/article/S0002-… No ⬆️ recurrences No ⬆️ mortality ‼️Bette#QoL‼️�� @oncoalert.bsky.social @weoncologists.bsky.social
"Vaginal Estrogen Use in Breast Cancer Survivors: A Systematic Review and Meta-Analysis of Recurrence and Mortality Risks" - American Journal of Obstetrics & Gynecology
To assess the risk of breast cancer recurrence, breast cancer-specific mortality, and overall mortality for breast cancer survivors receiving vaginal estrogen therapy for genitourinary syndrome of men...
www.ajog.org
November 22, 2024 at 8:19 PM
HIPEC in Platinum-Sensitive Recurrent #ovariancancer: RCT (HORSE; MITO-18) | @JCO_ASCO ascopubs.org/doi/10.1200/...

167 pts
median follow up 83mo
No NACT before SCS
mPFS:
- 23mo surgery alone
- 25mo surgery + HIPEC
No PFS benefit of adding HIPEC
@oncoalert.bsky.social @weoncologists.bsky.social
Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18) | Journal of Clinical Oncology
PURPOSETo investigate whether the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to secondary cytoreductive surgery (SCS) without neoadjuvant chemotherapy has a benefit on progression-f...
ascopubs.org
November 22, 2024 at 7:25 PM
Reposted by Fabio Martinelli
OncoAlert along with our partners at ESSO, ESGO, MASCC & SIOG Proudly Announce 1/3 of our faculty, more soon@

Register HERE
https://buff.ly/3CChgre

@elisabettabonzano.bsky.social
@elisaagostinetto.bsky.social
@realbowtiedoc.bsky.social
@erikahamilton9.bsky.social
@agerikssonmd.bsky.social
November 19, 2024 at 4:11 PM